New CSO at Sanofi

pharmafield logo - pharma news


Sanofi has appointed Dr David-Alexandre Gros as its new Chief Strategy Officer.

Dr Gros will join the group’s Executive Committee and oversee business development and acquisition activities, as well as other tasks including strategic planning and intelligence.

Christopher Viehbacher, Sanofi Chief Executive Officer, says the new CSO’s “wealth of experience” will “contribute significantly” to the company’s strategy and transformation.

He joins Sanofi after serving as an advisor to pharmaceutical, biotechnology and diagnostic companies as a Principal and founding member of Centerview Partners.